About Axiom Venture Partners
Axiom Venture Partners is a venture capital firm founded in 1994. It is primarily based out of Hartford, United States. As of Jun 2019, Axiom Venture Partners has invested in 44 companies. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series A round of Tangen Biosciences Overall, Axiom Venture Partners portfolio has seen 6 IPOs and 18 acquisitions including key companies like Dynavax, SPS Commerce and Sabre. A lot of funds co-invest with Axiom Venture Partners, with names like Kodiak Venture Partners sharing a substantial percentage of its portfolio. Axiom Venture Partners has team of 2 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 2 more
Portfolio Acquisitions
Axiom Venture Partners' List of Top Investments
Axiom Venture Partners has a portfolio of 44 companies. Their most notable investments are in SPS Commerce and SPS Commerce.Their portfolio spans across United States, Germany, India and 1 more locations. They have invested in Life Sciences, Enterprise Applications, High Tech and 15 other sectors, across stages such as Series A, Series C and 2 more. Here is the list of top investments by Axiom Venture Partners:1. Dynavax
Developer of products to prevent and treat infectious and inflammatory diseases and cancer. The lead candidate Heplisav-B Hepatitis B Vaccine combines TLR9 agonist and hepatitis B surface antigen. also developing DV2-HBV-25 for myocardial infarction, DV2-HBV-26 for immune-mediated herpes zoster, and others.
Key facts about Dynavax
- Founded Year: 1996
- Location: Berkeley (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2024
- Stage: Acquired
- Total Funding till date: $73.9M
- Employee Count: 269 as on Jul 31, 2026
- Investors: Piper Jaffray, Bain Capital Life Sciences and 27 Others
- Latest Funding Round: Post IPO, Aug 27, 2021, $*****
- Highlight: Acquired
2. SPS Commerce
Provider of cloud-based platform for retail supply chain management solutions. The company offers electronic data interchange, product information management, and supply chain performance monitoring. It also provides solutions for revenue recovery, order management, and analytics. The platform aims to streamline operations and improve information exchange between businesses and their partners.
Key facts about SPS Commerce
- Founded Year: 1998
- Location: Minneapolis (United States)
- Annual Revenue: $500M - $1B as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $50.5M
- Employee Count: 3,272 as on Jul 31, 2026
- Investors: Adams Street Partners, Seyen Capital and 6 Others
- Latest Funding Round: Series B, Jun 03, 2007, $*****
- Highlight: Public
3. Sabre
Provider of technology solutions for airlines, travel agencies, and corporate travel. The company offers platforms and applications that support airline retailing, content management, and customer management. It provides tools for offer and order management, data intelligence, and financial management. The company also delivers solutions for network planning, security management, and workflow optimization.
Key facts about Sabre
- Founded Year: 1960
- Location: Southlake (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 9,008 as on Jul 31, 2026
- Investors: Norwest, Sunstone Partners and 5 Others
- Latest Funding Round: Post IPO, Apr 13, 2020, $*****
- Highlight: Public
4. Tangoe
Cloud based platform offering IT expense life cycle management software. Using this platform customers can manage mobility assets, IT, telecom, and cloud. Matrix Telecom provides expense management invoice processing, auditing, dispute resolution, contract management, usage management, and more. It enables user access to a subscripiton-based pricing module.
Key facts about Tangoe
- Founded Year: 2000
- Location: Boulevard (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2014
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $34.2M
- Employee Count: 1,680 as on Jul 31, 2026
- Investors: Western Technology Investment, ORIX and 10 Others
- Latest Funding Round: Series F, Jan 2009, $*****
- Highlight: Acquired
5. Exelixis
Developer of small molecule drugs for the treatment of cancer. The company's lead product includes Cabozantinib that inhibits the activity of receptor tyrosine kinases and used for the treatment of metastatic medullary thyroid cancer (MTC). Its other products include Cobimetinib used for the treatment of Melanoma; XL888, an orally bioavailable ATP-competitive inhibitor of HSP90, a molecular chaperone protein that affects regulatory proteins.
Key facts about Exelixis
- Founded Year: 1994
- Location: San Francisco (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 1,571 as on Jul 31, 2026
- Investors: Atlas Venture, BB Biotech and 13 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2021, $*****
- Highlight: Public
Axiom Venture Partners' Year-on-Year Investment Trends
Axiom Venture Partners has invested in 44 companies over the last 27 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Tangen Biosciences and most recent follow-on round was in Melinta Therapeutics.Axiom Venture Partners' Investments by Stage
Axiom Venture Partners has made 6 investments in Series A stage with an average round size of $21.2M, 6 investments in Series C stage with an average round size of $10.4M, 4 investments in Series B stage with an average round size of $16.9M and 1 investment in Series E stage with an average round size of $2.7M.Stage of entry | No. of Investments |
|---|---|
Series A | 6 |
Series C | 6 |
Series B | 4 |
Series E | 1 |
Note: We have considered here, only first round of investments
Axiom Venture Partners' Investments by Sector
Axiom Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Enterprise Infrastructure, High Tech and Semiconductors. Notably, it has invested in 30 Enterprise (B2B) companies, 27 Tech companies, 10 Software companies and at least 7 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
Enterprise Applications | 3 |
Enterprise Infrastructure | 3 |
High Tech | 3 |
Semiconductors | 3 |
Others | 11 |
Note: We have considered here, only first round of investments
Axiom Venture Partners' Investments by Geography
Axiom Venture Partners has made most investments in United States (15), followed by Germany where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 15 |
Germany | 1 |
Netherlands | 1 |
Note: We have considered here, only first round of investments
Axiom Venture Partners' recent investments
Axiom Venture Partners has not made any investment in 2026 so far.Here are the most recent investments by Axiom Venture Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 20, 2019 | United States | Series A | 3645 | ||
Jan 26, 2009 | United States | Series C | 1626 | [+4] | |
Nov 28, 2006 | United States | Series E | 1605 | ||
Nov 07, 2006 | United States | Series A | 4144 | ||
Jun 20, 2006 | United States | Series C | 9028 | [+6] |
IPOs and Publicly Listed companies in Axiom Venture Partners' Portfolio
6 of Axiom Venture Partners' portfolio companies have become public. Shopping got listed on the New York Stock Exchange (NYSE), in May 2015 at marketcap of $131M and Sabre got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $4.14B.Here are Axiom Venture Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 22, 2015 | - | - | 6556 | |
Apr 17, 2014 | - | - | 5454 | |
Apr 22, 2010 | Feb 08, 2000 | Series A | 9405 | |
Oct 01, 2008 | - | - | 1723 | |
Apr 07, 2000 | - | - | 7112 |
Acquired companies in Axiom Venture Partners' Portfolio
18 companies from Axiom Venture Partners' portfolio have been acquired. The most recent acquisition was Dynavax in Dec 2025 by Sanofi for $*****.Here are Axiom Venture Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 24, 2025 | Jul 13, 1999 | Series B | 8197 | |
Aug 07, 2025 | Dec 31, 2001 | Series A | 8690 | |
Apr 28, 2017 | Feb 09, 2006 | Series E | 9003 | |
Jun 30, 2014 | Jan 04, 2006 | Series B | 1319 | |
Jan 14, 2013 | - | - | 9936 |
Team profile of Axiom Venture Partners
Axiom Venture Partners has a team of 2 members including 2 Partners located in United States. Axiom Venture Partners' team does not sit on the board of any company as of now.Co-investors of Axiom Venture Partners
Over the past 27 years, 112 investors have co-invested in Axiom Venture Partners's portfolio companies. This includes funds and angels.
- Invested before Axiom Venture Partners: Edison Partners, Tallwood Venture Capital and 19 others have invested in rounds before Axiom Venture Partners. There is 1 company where Edison Partners has invested before Axiom Venture Partners and 1 company where Tallwood Venture Capital has invested before Axiom Venture Partners.
- Top Co-investors of Axiom Venture Partners: 44 investors entered a company along with Axiom Venture Partners. These include investors like Kodiak Venture Partners (3 companies).
- Invested after Axiom Venture Partners: A total of 47 investors have invested in Axiom Venture Partners's portfolio after their investments. Top Investors include Advent International (2 companies), Care Capital (1 company) and Forward Ventures (1 company).
Recent News related to Axiom Venture Partners
•
Bridge Connector raises another $5.5M to build out its iPaaS solution for healthcareVator•Aug 28, 2018•Axiom Venture Partners, Intermedix, R1 RCM, Bridge Connector and 1 other
•
Startup offering integration solution raises $4.5M seed roundMedCity News•Jun 05, 2018•Axiom Venture Partners, Bridge Connector, Jeffrey Wenger, Jeffrey Wenger and 2 others
•
Bridge Connector raises $4.5M to integrate solutions for healthcare organizationsVator•Jun 05, 2018•Bridge Connector, Axiom Venture Partners, Jeffrey Wenger, Jeffrey Wenger and 2 others
•
•
ChipWrights Scores $18M in FinancingEDN•Apr 16, 2016•ChipWrights, Rock Maple Ventures, SpaceVest, Axiom Venture Partners and 2 others
•
Tangoe Raises $8 Million - PE HubPE Hub•Nov 28, 2006•Tangoe, North Atlantic Capital, Axiom Venture Partners, Edison Partners
•
Axiom Ventures / Press ReleaseAxiom Venture Partners•Mar 22, 2006•WellDog, EnerTech Capital, Axiom Venture Partners
•
•
Axiom Ventures / Press ReleaseAxiom Venture Partners•Jan 10, 2006•SilverStorm Technologies, Core Capital Partners, Axiom Venture Partners, Bay Partners and 1 other
•
